Testimony On HB 755: One PA for 12 Months for Prescription Drugs

We are neutral on House Bill 755 after working with Rep. Johnson on a forthcoming committee sub that will address our concerns and create some reasonable guardrails. We appreciate the author making changes to the bill to address concerns. 

As introduced, the bill would broadly eliminate almost all prior authorizations (PAs) for prescription drugs. The legislation’s definition of “chronic” is so broad that health plans would be prohibited from requiring a PA for nearly any drug. This includes verifying that opioids are prescribed according to guidelines at the lowest possible dose and for the shortest possible duration to help prevent overuse.

Read the full letter.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.